In 2004, Hospira was a relatively no-name biotech company. By 2015, it had pioneered a new form of injectable and was raking in 4.5 billion in revenue. Do you have the skill to spot the next shooting star in the biotech industry?
We are a team of industry vets that offer free advice to investors - spotting the fastest rising companies in biotech.


Aucun commentaire:
Enregistrer un commentaire
Remarque : Seul un membre de ce blog est autorisé à enregistrer un commentaire.